RAREUltragenyxHealth Care
$15.48EarningsNov 3, 2026
1D—1W—1M—3M—1Y—
Market cap$1.6BCompany infoRevenue$716.9M52-wk range$13 – $37IndustryBiotechnologyWebsiteultragenyx.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −49.0% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S2.2×5767
3
17
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin83.1%9487
83%
95%
Operating margin-73.8%13
-179%
-74%
Net margin-81.8%13
-197%
-82%
ROE———
ROIC-45.9%14
-1477%
-32%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity———
Net debt / EBITDA———
Current ratio1.736243
Interest coverage-6.9×38
Per shareTTM, with year-over-year change
Revenue / share$7.04▲ +18%
EPS (diluted)$-5.84▼ −6%
FCF / share$-4.80▼ −15%
Est. EPS growth (fwd)—